KOAN — Apollo Biowellness Balance Sheet
0.000.00%
- $2.93m
- $7.06m
- $1.90m
- 62
- 44
- 63
- 58
Annual balance sheet for Apollo Biowellness, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.114 | 0.013 | 0.064 | 0.007 | 0.008 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.055 | — | 0.15 | — | 0.056 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.169 | 0.27 | 0.375 | 0.977 | 1.03 |
| Net Property, Plant And Equipment | — | 0.031 | 0.024 | 0.015 | 0.015 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.169 | 0.301 | 0.399 | 0.992 | 1.85 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.17 | 4.4 | 1.55 | 3.13 | 5.05 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.17 | 4.4 | 1.55 | 3.13 | 5.05 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.996 | -4.1 | -1.15 | -2.14 | -3.2 |
| Total Liabilities & Shareholders' Equity | 0.169 | 0.301 | 0.399 | 0.992 | 1.85 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |